¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"macula densa cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
lacunar cell
°ø°£¼¼Æ÷
mitotic cell
À¯»çºÐ¿±â¼¼Æ÷
mitral cell
½Â¸ð¼¼Æ÷
mixed germ cell tumor
È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
monocyte-macrophage cell system
´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ÜÇÙ±¸´ë½Ä¼¼Æ÷°èÅë
mononuclear cell
´ÜÇÙ¼¼Æ÷, ´ÜÇÙ±¸
mossy cell
À̳¢¼¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
motor cell
¿îµ¿½Å°æ¼¼Æ÷
mucous cell
Á¡¾×¼¼Æ÷
mulberry cell
¿Àµð¼¼Æ÷
multinuclear giant cell
´ÙÇÙ°Å´ë¼¼Æ÷, ¹µÇÙ°Å´ë¼¼Æ÷
multipolar nerve cell
´Ù±Ø½Å°æ¼¼Æ÷, ¹µ±Ø½Å°æ¼¼Æ÷
myeloid cell
°ñ¼ö¼¼Æ÷
myeloma cell
°ñ¼öÁ¾¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
prickle cell
°¡½Ã¼¼Æ÷
primed cell
ÃÊȸ°¨ÀÛ¼¼Æ÷
primordial germ cell
¿ø½ÃÁ¾ÀÚ¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷
Purkinje cell
½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ô¼¼Æ÷
receptor cell
¼ö¿ëü¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
residential cell
Á¤ÁÖ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticular cell
±×¹°¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
reticulum cell
(¢¡reticular cell) ±×¹°¼¼Æ÷
rod cell
¸·´ë¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
hybridoma, B cell
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immortalized cell
¹«ÇÑÁõ½Ä¼¼Æ÷
immunity,cell-mediated
¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
cell maturation
¼¼Æ÷¼º¼÷
cell mediated hypersensitivity
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
cell mediated immunity
¼¼Æ÷¼º¸é¿ª.
cell mediated immunity deficiency syndrome
¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
cell mediated immunity deficiency syndrome
¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
cell mediated lympholysis
¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
cell mediated reaction
¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
cell mediated reaction
¼¼Æ÷¸Å°³¼º ¹ÝÀÀ.
cell membrane
¼¼Æ÷¸·
cell membrane
¼¼Æ÷¸·(á¬øàØ¯)
cell membrane
¼¼Æ÷¸·
cell membrane permeability
¼¼Æ÷¸·Åõ°ú¼º(á¬øàØ¯÷âΦàõ).
cell migration disorder
cell of parathyroid gland
ºÎ°©»ó»ù¼¼Æ÷
cell of reticulum
¹úÁýÀ§Ä
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½